We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
59.00 | 3.18% | 1,913.00 | 1,916.00 | 1,918.00 | 1,920.00 | 1,861.00 | 1,861.00 | 522,491 | 16:35:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 22.08 | 4.24B |
TIDMHIK
RNS Number : 1623D
Hikma Pharmaceuticals Plc
24 April 2017
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 Details of the person discharging managerial responsibilities / person closely associated ---- ------------------------------------------------------------------- a) Name Mary Regina (Nina) Henderson ---- ---------------------- ------------------------------------------- 2 Reason for the notification ---- ------------------------------------------------------------------- a) Position/status Non-Executive Director ---- ---------------------- ------------------------------------------- b) Initial notification Initial notification /Amendment ---- ---------------------- ------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---- ------------------------------------------------------------------- a) Name Hikma Pharmaceuticals PLC ---- ---------------------- ------------------------------------------- b) LEI 549300BNS685UXH4JI75 ---- ---------------------- ------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---- ------------------------------------------------------------------- a) Description Description: Ordinary shares of 10 of the financial pence each (Shares) instrument, ID Code: GB00B0LCW083 type of instrument and identification code ---- ---------------------- ------------------------------------------- b) Nature of Market purchase of 3,500 Ordinary the transaction Shares by the Mary R. Henderson Revocable Trust (the Trust). The Non-Executive Director is the sole trustee of the Trust. ---- ---------------------- ------------------------------------------- c) Price(s) and Price(s): $23.8966 volume(s) Volume(s): 3,500 ---- ---------------------- ------------------------------------------- Aggregated d) information * Volume 3,500 $83,638.10 * Price --------------------------- ------------------------------------------- e) Date of the 24 April 2017 transaction ---- ---------------------- ------------------------------------------- f) Place of the London Stock Exchange (XLON) transaction ---- ---------------------- -------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBSGDSDXDBGRS
(END) Dow Jones Newswires
April 24, 2017 10:35 ET (14:35 GMT)
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions